These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


203 related items for PubMed ID: 26905600

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Defective lipid metabolism in the failing heart.
    Wittels B, Spann JF.
    J Clin Invest; 1968 Aug; 47(8):1787-94. PubMed ID: 4233124
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Targets for modulation of fatty acid oxidation in the heart.
    Lopaschuk GD.
    Curr Opin Investig Drugs; 2004 Mar; 5(3):290-4. PubMed ID: 15083595
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Peroxisomes in cardiomyocytes and the peroxisome / peroxisome proliferator-activated receptor-loop.
    Colasante C, Chen J, Ahlemeyer B, Baumgart-Vogt E.
    Thromb Haemost; 2015 Mar; 113(3):452-63. PubMed ID: 25608554
    [Abstract] [Full Text] [Related]

  • 31. The failing heart--an engine out of fuel.
    Neubauer S.
    N Engl J Med; 2007 Mar 15; 356(11):1140-51. PubMed ID: 17360992
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women.
    Peterson LR, Herrero P, Schechtman KB, Racette SB, Waggoner AD, Kisrieva-Ware Z, Dence C, Klein S, Marsala J, Meyer T, Gropler RJ.
    Circulation; 2004 May 11; 109(18):2191-6. PubMed ID: 15123530
    [Abstract] [Full Text] [Related]

  • 34. Optimization of cardiac metabolism in heart failure.
    Nagoshi T, Yoshimura M, Rosano GM, Lopaschuk GD, Mochizuki S.
    Curr Pharm Des; 2011 Dec 11; 17(35):3846-53. PubMed ID: 21933140
    [Abstract] [Full Text] [Related]

  • 35. Targeting Myocardial Substrate Metabolism in the Failing Heart: Ready for Prime Time?
    Yurista SR, Chen S, Welsh A, Tang WHW, Nguyen CT.
    Curr Heart Fail Rep; 2022 Aug 11; 19(4):180-190. PubMed ID: 35567658
    [Abstract] [Full Text] [Related]

  • 36. The heart is better protected against myocardial infarction in the fed state compared to the fasted state.
    Liepinsh E, Makrecka M, Kuka J, Makarova E, Vilskersts R, Cirule H, Sevostjanovs E, Grinberga S, Pugovics O, Dambrova M.
    Metabolism; 2014 Jan 11; 63(1):127-36. PubMed ID: 24140100
    [Abstract] [Full Text] [Related]

  • 37. Maturation of fatty acid and carbohydrate metabolism in the newborn heart.
    Makinde AO, Kantor PF, Lopaschuk GD.
    Mol Cell Biochem; 1998 Nov 11; 188(1-2):49-56. PubMed ID: 9823010
    [Abstract] [Full Text] [Related]

  • 38. Potential mechanisms and consequences of cardiac triacylglycerol accumulation in insulin-resistant rats.
    Atkinson LL, Kozak R, Kelly SE, Onay Besikci A, Russell JC, Lopaschuk GD.
    Am J Physiol Endocrinol Metab; 2003 May 11; 284(5):E923-30. PubMed ID: 12464581
    [Abstract] [Full Text] [Related]

  • 39. The role of CD36 in the regulation of myocardial lipid metabolism.
    Kim TT, Dyck JR.
    Biochim Biophys Acta; 2016 Oct 11; 1861(10):1450-60. PubMed ID: 26995462
    [Abstract] [Full Text] [Related]

  • 40. Metabolic therapy of heart failure.
    Fragasso G, Salerno A, Spoladore R, Bassanelli G, Arioli F, Margonato A.
    Curr Pharm Des; 2008 Oct 11; 14(25):2582-91. PubMed ID: 18991675
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.